BACKGROUND: Alcohol is a well-established risk factor for head and neck cancer (HNC). This study aims to explore the effect of alcohol intensity and duration, as joint continuous exposures, on HNC risk. METHODS: Data from 26 case-control studies in the INHANCE Consortium were used, including never and current drinkers who drunk ≤10 drinks/day for ≤54 years (24234 controls, 4085 oral cavity, 3359 oropharyngeal, 983 hypopharyngeal and 3340 laryngeal cancers). The dose-response relationship between the risk and the joint exposure to drinking intensity and duration was investigated through bivariate regression spline models, adjusting for potential confounders, including tobacco smoking. RESULTS: For all subsites, cancer risk steeply increased with increasing drinks/day, with no appreciable threshold effect at lower intensities. For each intensity level, the risk of oral cavity, hypopharyngeal and laryngeal cancers did not vary according to years of drinking, suggesting no effect of duration. For oropharyngeal cancer, the risk increased with durations up to 28 years, flattening thereafter. The risk peaked at the higher levels of intensity and duration for all subsites (odds ratio = 7.95 for oral cavity, 12.86 for oropharynx, 24.96 for hypopharynx and 6.60 for larynx). CONCLUSIONS: Present results further encourage the reduction of alcohol intensity to mitigate HNC risk.

Boston University School of Public Health Boston MA USA

Branch of Medical Statistics Biometry and Epidemiology G A Maccacaro Department of Clinical Sciences and Community Health Università degli Studi di Milano Milano Italy

Brown University Providence Rhode Island RI USA

Cancer Epidemiology Unit Centro di Riferimento Oncologico di Aviano IRCCS Aviano Italy

Cancer Registry of Norway Oslo Norway

College of Public Health University of Iowa Iowa City IA USA

Department of Biomedical and Clinical Sciences University of Milan Milan Italy

Department of Cancer Epidemiology Nagoya University Graduate School of Medicine Nagoya Japan

Department of Economics Business Mathematics and Statistics University of Trieste Trieste Italy

Department of Epidemiology Brown University School of Public Health Providence RI USA

Department of Epidemiology Gillings School of Global Public Health Chapel Hill NC USA

Department of Epidemiology School of Public Health University of São Paulo São Paulo Brazil

Department of Hygiene Epidemiology and Medical Statistics School of Medicine National and Kapodistrian University of Athens Athens Greece

Department of Medical and Surgical Sciences University of Bologna Bologna Italy

Department of Medical Sciences University of Turin Turin Italy

Department of Otolaryngology Head and Neck Surgery Baylor College of Medicine Houston Texas USA

Department of Otorhinolaryngology School of Medicine and Surgery University of Milano Bicocca Monza Italy

Department of Pharmaceutical Sciences College of Pharmacy and Pharmaceutical Sciences Washington State University Spokane WA USA

Departments of Epidemiology and Environmental Health Sciences School of Public Health and Department of Urology Medical School University of Michigan Ann Arbor MI USA

Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD USA

Division of Cancer Epidemiology and Prevention Aichi Cancer Center Research Institute Nagoya Japan

Division of Epidemiology New York University School Of Medicine New York NY USA

Division of Head and Neck Surgical Oncology in the Department of Otolaryngology Head and Neck Surgery at Washington University School of Medicine St Louis MO USA

Division of Public Health Department of Family and Preventive Medicine University of Utah School of Medicine and Huntsman Cancer Institute Salt Lake City UT USA

Epidemiology CIPE ACCAMARGO Sao Paulo Brazil

Escola Nacional de Saude Publica Fundacao Oswaldo Cruz Rio de Janeiro Brazil

Head and Neck Surgery School of Medicine University of São Paulo São Paulo Brazil

Hospital Moinhos de Vento Porto Alegre Brazil

INSERM UMR 1018 Centre for Research in Epidemiology and Population Health Cancer Epidemiology Genes and Environment Team Villejuif France

Institut Universitaire de Médecine Sociale et Préventive Unisanté University of Lausanne Lausanne Switzerland

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

Institute of Oncology and Radiobiology Havana Cuba

Institute of Population Health Sciences National Health Research Institutes Miaoli Taiwan

Instituto de Oncología Ángel H Roffo Universidad de Buenos Aires Buenos Aires Argentina

International Agency for Research on Cancer Lyon France

Leibniz Institute for Prevention Research and Epidemiology BIPS Bremen Germany

Medical Informatics Center Peking University Beijing China

National Institute of Health and Medical Research INSERM U1018 Villejuif France

New York Eye and Ear Infirmary New York NY USA

Penn State College of Medicine Hershey PA USA

Program in Epidemiology Division of Public Health Sciences Fred Hutchinson Cancer Research Center Seattle WA USA

School of Medicine Dentistry and Nursing University of Glasgow Glasgow UK

School of Medicine Medical Sciences and Nutrition University of Aberdeen Aberdeen UK

Scientific Directorate Centro di Riferimento Oncologico di Aviano IRCCS Aviano Italy

The Tisch Cancer Institute Icahn School of Medicine at Mount Sinai New York NY USA

Thoracic Head and Neck Medical Oncology The University of Texas MD Anderson Cancer Center Houston TX USA

Trinity College School of Dental Science Dublin Ireland

UCLA School of Public Health Los Angeles CA USA

Unit of Nutrition and Cancer Catalan Institute of Oncology ICO Nutrition and Cancer Group Bellvitge Biomedical Research Institute IDIBELL L'Hospitalet de Llobregat Barcelona 08908 Spain

Universidade Federal de Pelotas Pelotas Brazil

Université de Rennes INSERM EHESP Irset UMR_S 1085 Pointe à Pitre France

University of Bremen Faculty of Mathematics and Computer Science Bremen Germany

University of Hong Kong Hong Kong China

University of Padua Padova Italy

000      

00000naa a2200000 a 4500

001      

bmc21012059

003      

CZ-PrNML

005      

20210507101819.0

007      

ta

008      

210420s2020 xxk f 000 0|eng||

009      

AR

024    7_

$a 10.1038/s41416-020-01031-z $2 doi

035    __

$a (PubMed)32830199

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxk

100    1_

$a Di Credico, Gioia $u Department of Economics, Business, Mathematics and Statistics, University of Trieste, Trieste, Italy

245    10

$a Alcohol drinking and head and neck cancer risk: the joint effect of intensity and duration / $c G. Di Credico, J. Polesel, L. Dal Maso, F. Pauli, N. Torelli, D. Luce, L. Radoï, K. Matsuo, D. Serraino, P. Brennan, I. Holcatova, W. Ahrens, P. Lagiou, C. Canova, L. Richiardi, CM. Healy, K. Kjaerheim, DI. Conway, GJ. Macfarlane, P. Thomson, A. Agudo, A. Znaor, S. Franceschi, R. Herrero, TN. Toporcov, RA. Moyses, J. Muscat, E. Negri, M. Vilensky, L. Fernandez, MP. Curado, A. Menezes, AW. Daudt, R. Koifman, V. Wunsch-Filho, AF. Olshan, JP. Zevallos, EM. Sturgis, G. Li, F. Levi, ZF. Zhang, H. Morgenstern, E. Smith, P. Lazarus, C. La Vecchia, W. Garavello, C. Chen, SM. Schwartz, T. Zheng, TL. Vaughan, K. Kelsey, M. McClean, S. Benhamou, RB. Hayes, MP. Purdue, M. Gillison, S. Schantz, GP. Yu, SC. Chuang, P. Boffetta, M. Hashibe, AL. Yuan-Chin, V. Edefonti

520    9_

$a BACKGROUND: Alcohol is a well-established risk factor for head and neck cancer (HNC). This study aims to explore the effect of alcohol intensity and duration, as joint continuous exposures, on HNC risk. METHODS: Data from 26 case-control studies in the INHANCE Consortium were used, including never and current drinkers who drunk ≤10 drinks/day for ≤54 years (24234 controls, 4085 oral cavity, 3359 oropharyngeal, 983 hypopharyngeal and 3340 laryngeal cancers). The dose-response relationship between the risk and the joint exposure to drinking intensity and duration was investigated through bivariate regression spline models, adjusting for potential confounders, including tobacco smoking. RESULTS: For all subsites, cancer risk steeply increased with increasing drinks/day, with no appreciable threshold effect at lower intensities. For each intensity level, the risk of oral cavity, hypopharyngeal and laryngeal cancers did not vary according to years of drinking, suggesting no effect of duration. For oropharyngeal cancer, the risk increased with durations up to 28 years, flattening thereafter. The risk peaked at the higher levels of intensity and duration for all subsites (odds ratio = 7.95 for oral cavity, 12.86 for oropharynx, 24.96 for hypopharynx and 6.60 for larynx). CONCLUSIONS: Present results further encourage the reduction of alcohol intensity to mitigate HNC risk.

650    _2

$a mladiství $7 D000293

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a senioři nad 80 let $7 D000369

650    _2

$a pití alkoholu $x škodlivé účinky $x epidemiologie $x patologie $7 D000428

650    _2

$a studie případů a kontrol $7 D016022

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a nádory hlavy a krku $x epidemiologie $x etiologie $7 D006258

650    _2

$a lidé $7 D006801

650    _2

$a nádory hrtanu $x epidemiologie $x etiologie $7 D007822

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a lidé středního věku $7 D008875

650    _2

$a nádory úst $x epidemiologie $x etiologie $7 D009062

650    _2

$a nádory orofaryngu $x epidemiologie $x etiologie $7 D009959

650    _2

$a rizikové faktory $7 D012307

650    _2

$a stupeň závažnosti nemoci $7 D012720

650    _2

$a kouření $x škodlivé účinky $x epidemiologie $x patologie $7 D012907

650    _2

$a časové faktory $7 D013997

650    _2

$a mladý dospělý $7 D055815

655    _2

$a časopisecké články $7 D016428

655    _2

$a Research Support, N.I.H., Extramural $7 D052061

655    _2

$a Research Support, N.I.H., Intramural $7 D052060

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Polesel, Jerry $u Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. polesel@cro.it

700    1_

$a Dal Maso, Luigino $u Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy. epidemiology@cro.it

700    1_

$a Pauli, Francesco $u Department of Economics, Business, Mathematics and Statistics, University of Trieste, Trieste, Italy

700    1_

$a Torelli, Nicola $u Department of Economics, Business, Mathematics and Statistics, University of Trieste, Trieste, Italy

700    1_

$a Luce, Daniele $u Université de Rennes, INSERM, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, Pointe-à-Pitre, France

700    1_

$a Radoï, Loredana $u INSERM UMR 1018, Centre for Research in Epidemiology and Population Health (CESP), Cancer Epidemiology, Genes and Environment Team, Villejuif, France

700    1_

$a Matsuo, Keitaro $u Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan $u Department of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

700    1_

$a Serraino, Diego $u Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

700    1_

$a Brennan, Paul $u International Agency for Research on Cancer, Lyon, France

700    1_

$a Holcatova, Ivana $u Institute of Hygiene & Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic

700    1_

$a Ahrens, Wolfgang $u Leibniz Institute for Prevention Research and Epidemiology, BIPS, Bremen, Germany $u University of Bremen, Faculty of Mathematics and Computer Science, Bremen, Germany

700    1_

$a Lagiou, Pagona $u Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

700    1_

$a Canova, Cristina $u University of Padua, Padova, Italy

700    1_

$a Richiardi, Lorenzo $u Department of Medical Sciences, University of Turin, Turin, Italy

700    1_

$a Healy, Claire M $u Trinity College School of Dental Science, Dublin, Ireland

700    1_

$a Kjaerheim, Kristina $u Cancer Registry of Norway, Oslo, Norway

700    1_

$a Conway, David I $u School of Medicine, Dentistry, and Nursing, University of Glasgow, Glasgow, UK

700    1_

$a Macfarlane, Gary J $u School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK

700    1_

$a Thomson, Peter $u University of Hong Kong, Hong Kong, China

700    1_

$a Agudo, Antonio $u Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, Nutrition and Cancer Group, Bellvitge Biomedical Research Institute-IDIBELL, L'Hospitalet de Llobregat, Barcelona, 08908, Spain

700    1_

$a Znaor, Ariana $u International Agency for Research on Cancer, Lyon, France

700    1_

$a Franceschi, Silvia $u Scientific Directorate, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Aviano, Italy

700    1_

$a Herrero, Rolando $u International Agency for Research on Cancer, Lyon, France

700    1_

$a Toporcov, Tatiana N $u Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil

700    1_

$a Moyses, Raquel A $u Head and Neck Surgery, School of Medicine, University of São Paulo, São Paulo, Brazil

700    1_

$a Muscat, Joshua $u Penn State College of Medicine, Hershey, PA, USA

700    1_

$a Negri, Eva $u Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy

700    1_

$a Vilensky, Marta $u Instituto de Oncología Ángel H. Roffo, Universidad de Buenos Aires, Buenos Aires, Argentina

700    1_

$a Fernandez, Leticia $u Institute of Oncology and Radiobiology, Havana, Cuba

700    1_

$a Curado, Maria Paula $u Epidemiology-CIPE/ACCAMARGO, Sao Paulo, Brazil

700    1_

$a Menezes, Ana $u Universidade Federal de Pelotas, Pelotas, Brazil

700    1_

$a Daudt, Alexander W $u Hospital Moinhos de Vento, Porto Alegre, Brazil

700    1_

$a Koifman, Rosalina $u Escola Nacional de Saude Publica, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil

700    1_

$a Wunsch-Filho, Victor $u Department of Epidemiology, School of Public Health, University of São Paulo, São Paulo, Brazil

700    1_

$a Olshan, Andrew F $u Department of Epidemiology, Gillings School of Global Public Health, Chapel Hill, NC, USA

700    1_

$a Zevallos, Jose P $u Division of Head and Neck Surgical Oncology in the Department of Otolaryngology/Head and Neck Surgery at Washington University School of Medicine, St Louis, MO, USA

700    1_

$a Sturgis, Erich M $u Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA

700    1_

$a Li, Guojun $u Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas, USA

700    1_

$a Levi, Fabio $u Institut Universitaire de Médecine Sociale et Préventive (IUMSP), Unisanté, University of Lausanne, Lausanne, Switzerland

700    1_

$a Zhang, Zuo-Feng $u UCLA School of Public Health, Los Angeles, CA, USA

700    1_

$a Morgenstern, Hal $u Departments of Epidemiology and Environmental Health Sciences, School of Public Health and Department of Urology, Medical School, University of Michigan, Ann Arbor, MI, USA

700    1_

$a Smith, Elaine $u College of Public Health, University of Iowa, Iowa City, IA, USA

700    1_

$a Lazarus, Philip $u Department of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA, USA

700    1_

$a La Vecchia, Carlo $u Branch of Medical Statistics, Biometry and Epidemiology "G. A. Maccacaro", Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy

700    1_

$a Garavello, Werner $u Department of Otorhinolaryngology, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy

700    1_

$a Chen, Chu $u Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

700    1_

$a Schwartz, Stephen M $u Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

700    1_

$a Zheng, Tongzhang $u Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA

700    1_

$a Vaughan, Thomas L $u Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

700    1_

$a Kelsey, Karl $u Brown University, Providence, Rhode Island, RI, USA

700    1_

$a McClean, Michael $u Boston University School of Public Health, Boston, MA, USA

700    1_

$a Benhamou, Simone $u National Institute of Health and Medical Research, INSERM U1018, Villejuif, France

700    1_

$a Hayes, Richard B $u Division of Epidemiology, New York University School Of Medicine, New York, NY, USA

700    1_

$a Purdue, Mark P $u Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA

700    1_

$a Gillison, Maura $u "Thoracic/Head and Neck Medical Oncology", The University of Texas MD Anderson Cancer Center, Houston, TX, USA

700    1_

$a Schantz, Stimson $u New York Eye and Ear Infirmary, New York, NY, USA

700    1_

$a Yu, Guo-Pei $u Medical Informatics Center, Peking University, Beijing, China

700    1_

$a Chuang, Shu-Chun $u Institute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan

700    1_

$a Boffetta, Paolo $u Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy $u The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA

700    1_

$a Hashibe, Mia $u Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, UT, USA

700    1_

$a Yuan-Chin, Amy Lee $u Division of Public Health, Department of Family & Preventive Medicine, University of Utah School of Medicine and Huntsman Cancer Institute, Salt Lake City, UT, USA

700    1_

$a Edefonti, Valeria $u Branch of Medical Statistics, Biometry and Epidemiology "G. A. Maccacaro", Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milano, Italy

773    0_

$w MED00009369 $t British journal of cancer $x 1532-1827 $g Roč. 123, č. 9 (2020), s. 1456-1463

856    41

$u https://pubmed.ncbi.nlm.nih.gov/32830199 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20210420 $b ABA008

991    __

$a 20210507101818 $b ABA008

999    __

$a ok $b bmc $g 1650440 $s 1132438

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2020 $b 123 $c 9 $d 1456-1463 $e 20200824 $i 1532-1827 $m British journal of cancer $n Br J Cancer $x MED00009369

GRA    __

$a P01 CA068384 $p NCI NIH HHS $2 United States

GRA    __

$a K07 CA104231 $p NCI NIH HHS $2 United States

GRA    __

$a R01 CA048996 $p NCI NIH HHS $2 United States

GRA    __

$a R01 DA012609 $p NIDA NIH HHS $2 United States

GRA    __

$a R01 AG061188 $p NIA NIH HHS $2 United States

GRA    __

$a P01 CA068384 $p NCI NIH HHS $2 United States

GRA    __

$a K07 CA104231 $p NCI NIH HHS $2 United States

GRA    __

$a R01 DE013158 $p NIDCR NIH HHS $2 United States

GRA    __

$a P50 CA090388 $p NCI NIH HHS $2 United States

GRA    __

$a R01 DA011386 $p NIDA NIH HHS $2 United States

GRA    __

$a R03 CA077954 $p NCI NIH HHS $2 United States

GRA    __

$a T32 CA009142 $p NCI NIH HHS $2 United States

GRA    __

$a U01 CA096134 $p NCI NIH HHS $2 United States

GRA    __

$a R21 ES011667 $p NIEHS NIH HHS $2 United States

GRA    __

$a R01 CA078609 $p NCI NIH HHS $2 United States

GRA    __

$a R01 CA100679 $p NCI NIH HHS $2 United States

GRA    __

$a R01 CA031845 $p NCI NIH HHS $2 United States

GRA    __

$a R01 CA030022 $p NCI NIH HHS $2 United States

GRA    __

$a R03 CA113157 $p NCI NIH HHS $2 United States

GRA    __

$a R01 CA090731 $p NCI NIH HHS $2 United States

GRA    __

$a R03 DE016611 $p NIDCR NIH HHS $2 United States

GRA    __

$a R01 DA011979 $p NIDA NIH HHS $2 United States

GRA    __

$a R01 DE013110 $p NIDCR NIH HHS $2 United States

LZP    __

$a Pubmed-20210420